Clinical Neuroscience Research Laboratory, Department of Neurology, Hospital Clínico Universitario, University of Santiago de Compostela, Santiago de Compostela, Spain.
Clin Immunol. 2011 May;139(2):193-8. doi: 10.1016/j.clim.2011.02.001. Epub 2011 Feb 26.
Toll-like receptors are innate immunity receptors that activate inflammation and adaptive immunity. Our objectives were to analyze the association between TLR3, 7, 8 and 9 expressions and clinical outcome in patients with ischemic stroke and the expression of inflammatory molecules. One hundred-ten patients with ischemic stroke were included within 12h of symptoms onset. Stroke severity was evaluated by the NIHSS, and functional outcome was assessed at 3 months by the modified Rankin Scale. Infarct volume at 4-7 days was measured on Computed Tomography imaging. TLR7 and TLR8 at different time points were independently associated with poor outcome. TLR8 was also correlated with infarct volumes. Furthermore, TLR7 and TLR8 on admission were correlated with levels of IL6 and IL1β at 24h, 72 h and 7 days. In conclusion, TLR 7 and TLR8 expressions are associated with poor outcome and greater inflammatory response in acute ischemic stroke.
Toll 样受体是先天免疫受体,可激活炎症和适应性免疫。我们的目的是分析 TLR3、7、8 和 9 的表达与缺血性脑卒中患者的临床结果以及炎症分子的表达之间的关系。发病后 12 小时内纳入了 110 例缺血性脑卒中患者。NIHSS 评估卒中严重程度,改良 Rankin 量表在 3 个月时评估功能结局。在发病后 4-7 天通过计算机断层扫描测量梗死体积。在不同时间点,TLR7 和 TLR8 与不良结局独立相关。TLR8 还与梗死体积相关。此外,入院时的 TLR7 和 TLR8 与 24 小时、72 小时和 7 天的 IL6 和 IL1β 水平相关。总之,TLR7 和 TLR8 的表达与急性缺血性脑卒中的不良结局和更强的炎症反应相关。